Europe
Europe votes yes on greater trial transparency
June 3, 2013Research and Development, Sales and Marketing Europe, Goldacre, alltrials, transparency
Europe has taken one step closer to increasing clinical trial transparency on the continent after MEPs voted yes on new …
Roche restructures life science business
April 24, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Europe, Roche, US, cuts
Roche is to cut around 170 jobs in Europe and the US as part of a restructure of its life …
GSK hit by European austerity again
November 1, 2012Sales and Marketing Europe, GSK, Q3, austerity
GlaxoSmithKline suffered in the third quarter as sales fell 5% due to generic competition and austerity measures in Europe.Exceptional sales …
Europe looking to revamp clinical trial laws
July 25, 2012Research and Development, Sales and Marketing EFPIA, EU, Europe, clinical trials
The European Commission has put forward new proposals aimed at revamping clinical trial laws. The legislation will replace rules that …
Ariad touts next generation CML treatment
June 29, 2012Research and Development, Sales and Marketing Ariad, CML, Cancer, Europe, Switzerland
Ariad Pharmaceuticals is to expand into Europe following promising results for an investigational cancer drug. The US biotech firm will …
Lundbeck to slash 600 jobs in Europe
June 15, 2012Sales and Marketing Cipralex, Europe, Lundbeck, austerity, cuts
Lundbeck will cut 600 jobs from its operations in Europe as its Cipralex parent expiry continues to erode revenue. The …
Europe’s CMO market set to double by 2018, says F&S
May 30, 2012Manufacturing and Production CMO, Europe, F&S, R&D, Taylor, manufacturing
The European market for pharmaceutical contract manufacturing will double from a value of around $10 billion last year to almost …
Landmark CF treatment set for European approval
May 30, 2012Sales and Marketing CHMP, Europe, Kalydeco, Vertex, cystic fibrosis
A European committee is recommending the approval of Vertex’s first-in-class treatment for cystic fibrosis. Kalydeco (ivacaftor) is a landmark in …
European OK for Pradaxa, but more details required
May 29, 2012Research and Development, Sales and Marketing Boehringer, CHMP, EMA, Europe, Pradaxa
The European Medicines Agency says that Boehringher’s Pradaxa can stay on the market, but will need more safety information. The …
Can Europe really agree to speed up pricing and reimbursement?
March 6, 2012Sales and Marketing Europe, European Commission, GSK, Sir Andrew Witty, pricing and reimbursement
The European Commission has called for faster decisions to allow new medicines to enter the market faster.The Commission says the …
Glivec cleared for longer use in GIST patients
February 28, 2012Sales and Marketing Europe, GIST, Gleevec, Glivec, Novartis
Glivec has gained EU approval for extended use after surgery for adults with KIT (CD117)-positive gastrointestinal stromal tumours (GIST).The drug …
Witty hits out at ‘systematic delays’ to medicines
February 27, 2012Sales and Marketing Europe, GSK, NICE, austerity
GlaxoSmithKline’s chief executive says Europe’s drug budget cuts are undermining the industry and not addressing the biggest cost pressure in …
2011 Year In Review
January 6, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2011, Europe, emerging markets, year in review
A round up of some of the key themes in pharma’s yearEUROPE IN CRISIS While the Eurozone has averted meltdown …
Andreas Pott appointed deputy executive director of European Medicines Agency
November 21, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, Europe
The European Medicines Agency’s new executive director Guido Rasi has appointed Andreas Pott as deputy executive director. Pott’s appointment follows …
Industry supports bid to revitalise antibiotic research
November 17, 2011Research and Development, Sales and Marketing EFPIA, Europe, IMI, antibiotic
The European Commission and the European pharma industry have unveiled plans to accelerate the discovery and development of new antibiotics. …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
